FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| Eprodisate Sodium, 36589-58-9 ; 21668-77-9 (free), Eprodisate Sodium Intermediate 1120-71-4, stock 804.6g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| Eprodisate Sodium, 36589-58-9 ; 21668-77-9 (free), Eprodisate Sodium Intermediate 109-64-8, stock 739.6g, white powder, assay by HPLC 99.6%, HNMR, LCMS we supply. |
